Imovax rabies
Selected indexed studies
- Rabies Vaccine. (, 2006) [PMID:30000149]
- Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults. (Vaccine, 2024) [PMID:38105138]
- Vaccines for travelers. (Med Lett Drugs Ther, 2018) [PMID:30625125]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Vaccines for travelers. (2018) pubmed
- Rabies Vaccine. (2006) pubmed
- Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults. (2024) pubmed
- Post-Marketing Surveillance of Human Rabies Diploid Cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990‒2015. (2016) pubmed
- Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial. (2024) pubmed
- Factors influencing rabies vaccines immunogenicity during post-exposure prophylaxis: a systematic literature search and meta-analysis. (2026) pubmed
- Inhibitory effect of concomitantly administered rabies immunoglobulins on the immunogenicity of commercial and candidate human rabies vaccines in hamsters. (2022) pubmed
- From the Centers for Disease Control and Prevention. Voluntary recall of IMOVAX registered rabies I.D. (rabies vaccine) used for pre-exposure prophylaxis. (2000) pubmed
- Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults. (2023) pubmed
- Expanded table: Some vaccines for travelers. (2018) pubmed